APA

Waldschmidt J. M., Keller A., Ihorst G., Grishina O., Müller S., Wider D., Frey A. V., King K., Simon R., May A., Tassone P., Duyster J., Jung M., Raje N., Wäsch R. & Engelhardt M. (20191008). Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma). : Haematologica.

Chicago

Waldschmidt Johannes M, Keller Alexander, Ihorst Gabriele, Grishina Olga, Müller Stefan, Wider Dagmar, Frey Anna V, King Kristina, Simon Roman, May Annette, Tassone Pierfrancesco, Duyster Justus, Jung Manfred, Raje Noopur, Wäsch Ralph and Engelhardt Monika. 20191008. Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma). : Haematologica.

Harvard

Waldschmidt J. M., Keller A., Ihorst G., Grishina O., Müller S., Wider D., Frey A. V., King K., Simon R., May A., Tassone P., Duyster J., Jung M., Raje N., Wäsch R. and Engelhardt M. (20191008). Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma). : Haematologica.

MLA

Waldschmidt Johannes M, Keller Alexander, Ihorst Gabriele, Grishina Olga, Müller Stefan, Wider Dagmar, Frey Anna V, King Kristina, Simon Roman, May Annette, Tassone Pierfrancesco, Duyster Justus, Jung Manfred, Raje Noopur, Wäsch Ralph and Engelhardt Monika. Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma). : Haematologica. 20191008.